The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Discovery-Global Market Insights and Sales Trends 2024
Synopsis
The global Drug Discovery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery in various end use industries. The expanding demands from the Research Institutes, Pharmaceutical Companies and Biotechnology Companies,, are propelling Drug Discovery market. Small Molecule Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biologics Drug segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Drug Discovery market, driven by demand from China, the second largest economy with some signs of stabilising, the Drug Discovery market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Discovery covered in this report include Pfizer, GSK, Merck, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott and AstraZeneca, etc.
The global Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
Merck
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Global Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery market, Segment by Type:
Small Molecule Drug
Biologics Drug
Global Drug Discovery market, by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Drug Discovery market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Drug Discovery in various end use industries. The expanding demands from the Research Institutes, Pharmaceutical Companies and Biotechnology Companies,, are propelling Drug Discovery market. Small Molecule Drug, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Biologics Drug segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Drug Discovery market, driven by demand from China, the second largest economy with some signs of stabilising, the Drug Discovery market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Discovery, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Discovery market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Discovery market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Discovery sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Discovery covered in this report include Pfizer, GSK, Merck, Agilent, Eli Lilly and Company, Roche, Bayer, Abbott and AstraZeneca, etc.
The global Drug Discovery market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
Merck
Agilent
Eli Lilly and Company
Roche
Bayer
Abbott
AstraZeneca
Shimadzu
Global Drug Discovery market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Discovery market, Segment by Type:
Small Molecule Drug
Biologics Drug
Global Drug Discovery market, by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Discovery companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drug Discovery
1.1 Drug Discovery Market Overview
1.1.1 Drug Discovery Product Scope
1.1.2 Drug Discovery Market Status and Outlook
1.2 Global Drug Discovery Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Discovery Market Size by Region (2018-2029)
1.4 Global Drug Discovery Historic Market Size by Region (2018-2023)
1.5 Global Drug Discovery Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Discovery Market Size (2018-2029)
1.6.1 North America Drug Discovery Market Size (2018-2029)
1.6.2 Europe Drug Discovery Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Discovery Market Size (2018-2029)
1.6.4 Latin America Drug Discovery Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Discovery Market Size (2018-2029)
2 Drug Discovery Market by Type
2.1 Introduction
2.1.1 Small Molecule Drug
2.1.2 Biologics Drug
2.2 Global Drug Discovery Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Discovery Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Discovery Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Discovery Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Discovery Revenue Breakdown by Type (2018-2029)
3 Drug Discovery Market Overview by Application
3.1 Introduction
3.1.1 Research Institutes
3.1.2 Pharmaceutical Companies
3.1.3 Biotechnology Companies
3.2 Global Drug Discovery Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Discovery Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Discovery Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Discovery Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Discovery Revenue Breakdown by Application (2018-2029)
4 Drug Discovery Competition Analysis by Players
4.1 Global Drug Discovery Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Discovery as of 2022)
4.3 Date of Key Players Enter into Drug Discovery Market
4.4 Global Top Players Drug Discovery Headquarters and Area Served
4.5 Key Players Drug Discovery Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Discovery Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Drug Discovery Products, Services and Solutions
5.1.4 Pfizer Drug Discovery Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 GSK
5.2.1 GSK Profile
5.2.2 GSK Main Business
5.2.3 GSK Drug Discovery Products, Services and Solutions
5.2.4 GSK Drug Discovery Revenue (US$ Million) & (2018-2023)
5.2.5 GSK Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Drug Discovery Products, Services and Solutions
5.3.4 Merck Drug Discovery Revenue (US$ Million) & (2018-2023)
5.3.5 Agilent Recent Developments
5.4 Agilent
5.4.1 Agilent Profile
5.4.2 Agilent Main Business
5.4.3 Agilent Drug Discovery Products, Services and Solutions
5.4.4 Agilent Drug Discovery Revenue (US$ Million) & (2018-2023)
5.4.5 Agilent Recent Developments
5.5 Eli Lilly and Company
5.5.1 Eli Lilly and Company Profile
5.5.2 Eli Lilly and Company Main Business
5.5.3 Eli Lilly and Company Drug Discovery Products, Services and Solutions
5.5.4 Eli Lilly and Company Drug Discovery Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly and Company Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Drug Discovery Products, Services and Solutions
5.6.4 Roche Drug Discovery Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 Bayer
5.7.1 Bayer Profile
5.7.2 Bayer Main Business
5.7.3 Bayer Drug Discovery Products, Services and Solutions
5.7.4 Bayer Drug Discovery Revenue (US$ Million) & (2018-2023)
5.7.5 Bayer Recent Developments
5.8 Abbott
5.8.1 Abbott Profile
5.8.2 Abbott Main Business
5.8.3 Abbott Drug Discovery Products, Services and Solutions
5.8.4 Abbott Drug Discovery Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Profile
5.9.2 AstraZeneca Main Business
5.9.3 AstraZeneca Drug Discovery Products, Services and Solutions
5.9.4 AstraZeneca Drug Discovery Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca Recent Developments
5.10 Shimadzu
5.10.1 Shimadzu Profile
5.10.2 Shimadzu Main Business
5.10.3 Shimadzu Drug Discovery Products, Services and Solutions
5.10.4 Shimadzu Drug Discovery Revenue (US$ Million) & (2018-2023)
5.10.5 Shimadzu Recent Developments
6 North America
6.1 North America Drug Discovery Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Discovery Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Discovery Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Discovery Market Dynamics
11.1 Drug Discovery Industry Trends
11.2 Drug Discovery Market Drivers
11.3 Drug Discovery Market Challenges
11.4 Drug Discovery Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
